Dr. Cannabis
Dr. Cannabis is a Brazilian online education platform selling LMS-delivered medicinal cannabis courses to physicians, dentists, allied health professionals, and entrepreneurs, helping legally authorized practitioners gain the training and confidence to prescribe cannabinoids.
- Company typePrivate
- Founded2023
- HeadquartersSão Paulo, Brazil
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Dr. Cannabis does
Dr. Cannabis is a Brazilian online education platform, operated by CANNECT SERVIÇOS DE INTERNET S/A (CNPJ 41.418.943/0001-16) and headquartered in the Vila Olímpia district of São Paulo. The platform delivers video-based courses and educational content on medicinal cannabis to healthcare and business professionals, addressing the gap in which fewer than 1% of Brazilian doctors with an active CRM (medical registration) regularly prescribe cannabinoids despite legal authorization since 2015. It serves three vertical segments organized as learning tracks: physicians and dentists seeking to prescribe cannabinoids (Médicos e Odontologistas), allied health professionals such as psychologists and nurses who support patients in therapy (Profissionais da Saúde), and entrepreneurs entering the cannabis market (Negócios).
The product is built on a learning management system (LMS) that hosts video courses and educational materials with account registration that verifies professional council credentials (CRM, CRO, or student status). Core offerings include the flagship foundational course "Cannabis Medicinal do Zero 2026," a dental-focused variant "Cannabis Medicinal do Zero: Odontologia," and a shorter condition-specific course "Ansiedade e Transtornos do Sono," alongside a free supplementary content module used as a top-of-funnel lead capture. There is no evidence of a mobile app, public API, or proprietary AI/ML technology.
The business model is transactional course sales: one-time purchases granting 12-month access at fixed BRL price points with promotional discounts (flagship courses at R$3,000 list / R$2,700 promotional; the anxiety course at R$399 list / R$199 promotional). Go-to-market is self-serve/product-led, driven by content marketing, SEO, organic social media, and a blog, with direct enrollment via course landing pages. The platform is integrated into the broader Cannect ecosystem — operated by the same parent entity — which handles patient telemedicine and cannabis product distribution, redirecting patients to cannect.life for treatment continuity while Cannect drives patient volume that can convert into course enrollments.
Dr. Cannabis firmographics
Firmographics- Name
- Dr. Cannabis
- Legal name
- CANNECT SERVIÇOS DE INTERNET S/A
- Website
- https://drcannabis.com.br
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Dr. Cannabis is a Brazilian online education platform selling LMS-delivered medicinal cannabis courses to physicians, dentists, allied health professionals, and entrepreneurs, helping legally authorized practitioners gain the training and confidence to prescribe cannabinoids.
- Ownership category
- akta.pro rank
Where Dr. Cannabis is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Dr. Cannabis business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Technology or R&D, Operations
Revenue model
- Course Sales: The company generates revenue through one-time purchase of online courses for medicinal cannabis education. Courses are sold at fixed price points with occasional promotional discounts. Students gain 12-month access upon enrollment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Annual | Cannabis Medicinal do Zero 2026 - Core foundational course for medicinal cannabis prescribing |
| One time/ perpetual license | Annual | Cannabis Medicinal do Zero: Odontologia - Dental-focused medicinal cannabis course |
| One time/ perpetual license | Pay-as-you-go | Ansiedade e Transtornos do Sono - Course on anxiety and sleep disorders treatment with cannabis |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Dr. Cannabis product offering
Product offeringCore offering
Dr. Cannabis operates an online education platform that sells self-paced video courses training healthcare professionals (physicians, dentists, psychologists, nurses) and business professionals in medicinal cannabis prescribing, patient support, and cannabis market entry. Courses are delivered via a web-based LMS with 12-month access, sold individually at fixed Brazilian Real price points (R$199–R$2,700). The platform addresses the gap in Brazil where less than 1% of authorized doctors prescribe cannabinoids despite legality since 2015.
Product overview
Dr. Cannabis is an online education platform offering personalized training and courses for the medical cannabis market in Brazil. The platform operates as a unified course ecosystem with three specialized learning tracks: (1) Médicos e Odontologistas for physicians and dentists focused on prescribing cannabinoids, (2) Profissionais da Saúde for psychologists and nurses supporting patients in therapy, and (3) Negócios for entrepreneurs entering the cannabis business market. Core products include the flagship 'Cannabis Medicinal do Zero 2026' foundational course (R$2,700), the dental-specific 'Cannabis Medicinal do Zero: Odontologia' course (R$2,700), and the focused 'Ansiedade e Transtornos do Sono' course (R$199). The platform also provides a free supplementary content module. Patients are redirected to the Cannect platform for medicinal cannabis products. All courses are delivered via the company's LMS with 12-month access periods.
Differentiator
Problem solved
Functional benefit
Products and services
- Cannabis Medicinal do Zero 2026 Comprehensive foundational course training healthcare professionals to prescribe and recommend cannabinoid-based treatments in Brazil. Includes 12-month access and is priced at R$2,700 promotional (R$3,000 original).
- Cannabis Medicinal do Zero: Odontologia Specialized course for dental professionals on the use of cannabinoids in chronic oral pathologies and patient referral pathways for cannabis treatment. Includes 12-month access at R$2,700 promotional (R$3,000 original).
- Ansiedade e Transtornos do Sono Focused course on clinical hypotheses and evidence for using cannabis products in managing anxiety disorders and sleep disturbances. Includes 12-month access at R$199 promotional (R$399 original).
- Conte\u00fado Complementar Gratuito Free supplementary educational content allowing prospective students to explore medicinal cannabis topics before committing to a paid course.
Quantifiable outcome
- 554% growth in medical cannabinoid prescriptions in Brazil demonstrates massive market opportunity for trained professionals
- +2 more outcomes
Companies that use Dr. Cannabis
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Dr. Cannabis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Dr. Cannabis partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CannectcoreCannect is an integrated partner platform that provides medicinal cannabis products and telemedicine services for patients requiring medical prescriptions. Dr. Cannabis redirects existing patients to Cannect for continued treatment and product access, while Cannect drives patient volume that may convert to course enrollments. The partnership creates a complete ecosystem connecting patient care, doctor training, and cannabis product access. Both platforms are operated by CANNECT SERVIÇOS DE INTERNET S/A.
Scale indicators9 records
Dr. Cannabis competitors and assessment
Company assessmentOthers
- Leafly: Global cannabis information and education platform with practitioner- and patient-facing content; thematically adjacent to Dr. Cannabis's educational/market-narrative role, but does not sell professional certification courses.
Direct peers
- MM411: Online training and certification company focused on medical and retail cannabis for healthcare and dispensary staff; directly overlaps Dr. Cannabis's medical-professional certification positioning and clinical content library.
- THC University: Self-paced online cannabis training platform offering multiple professional tracks (budtender, grower, extraction) with a one-time-purchase course catalog analogous to Dr. Cannabis's three-track model.
- Green Flower Media: Online cannabis education platform delivering expert-led courses and certificate programs across consumer, patient, and professional audiences; competes head-to-head with Dr. Cannabis for cannabis-curious learners via self-serve video content.
- Cannabis Training University: Long-running online cannabis certification school offering self-paced video courses for budtenders, patients, and professionals; near-identical GTM, course format, and certification mechanic to Dr. Cannabis.
- The Medical Cannabis Institute: A US-based online training provider offering certification courses in clinical cannabis for healthcare professionals; directly comparable to Dr. Cannabis's flagship “Cannabis Medicinal do Zero” offering targeting physicians and dentists.
Regional players
- Afya: Largest Brazilian medical-education company (medicine prep, residency, continuing education); serves as a strategic benchmark and adjacent competitor for any Brazil-based platform selling professional medical certifications such as Dr. Cannabis.
Emerging players
- Veriheal: Online cannabis education and patient-to-doctor matchmaking platform; overlaps Dr. Cannabis + Cannect combined ecosystem but operates more as a patient-acquisition funnel than as a depth-of-training platform.
- Marijuana Business Daily: Cannabis industry intelligence, events, and educational content provider; comparable to Dr. Cannabis's Negócios track and broader cannabis-business education lane, but monetises via media/events rather than course sales.
Market position
Strengths5 records
Weaknesses5 records
Key risks6 records
Key highlights6 records
Customer concentration
Dr. Cannabis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dr. Cannabis leadership team
Management profileNumber of profiles
Dr. Cannabis funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dr. Cannabis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dr. Cannabis
What does Dr. Cannabis do?
Dr. Cannabis operates an online education platform that sells self-paced video courses training healthcare professionals (physicians, dentists, psychologists, nurses) and business professionals in medicinal cannabis prescribing, patient support, and cannabis market entry. Courses are delivered via a web-based LMS with 12-month access, sold individually at fixed Brazilian Real price points (R$199–R$2,700). The platform addresses the gap in Brazil where less than 1% of authorized doctors prescribe cannabinoids despite legality since 2015.
Is Dr. Cannabis a public or private company?
Dr. Cannabis is a private company. It is classified as unknown and is currently operating.
When was Dr. Cannabis founded?
Dr. Cannabis was founded in 2023. It employs 1 to 10 people.
Where is Dr. Cannabis based?
Dr. Cannabis is headquartered in São Paulo, Brazil, in the Latin America region.
How does Dr. Cannabis make money?
One revenue line is on record: course Sales.
Who are Dr. Cannabis's main competitors?
Leafly is listed as an others. Direct peers are MM411, THC University, Green Flower Media, Cannabis Training University and The Medical Cannabis Institute. Afya is listed as a regional player. Emerging players are Veriheal and Marijuana Business Daily.
Does Dr. Cannabis have an API?
No public API is recorded for Dr. Cannabis.